Elanco Animal Health Incorporated Common Stock (ELAN) is a publicly traded Healthcare sector company. As of September 10, 2026, ELAN trades at $23.28 with a market cap of $11.98B and a P/E ratio of -57.91. ELAN moved -1.23% today. Year to date, ELAN is +4.07%; over the trailing twelve months it is +25.53%. Its 52-week range spans $8.02 to $27.98. Analyst consensus is strong buy with an average price target of $31.33. Rallies surfaces ELAN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ELAN news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $23.28 |
| Market Cap | $11.98B |
| P/E Ratio | -57.91 |
| EPS | $-0.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.98 |
| 52-Week Low | $8.02 |
| Volume | 416.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.02B |
| Net Income | $-199.00M |
| Gross Margin | 55.36% |
12 analysts cover ELAN: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $31.33.